A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014

Abstract

BACKGROUND: Despite considerable public health burden, uterine fibroid population-based incidence estimates are few. Secular trends over time are even more limited. OBJECTIVE: We sought to evaluate the incidence, 10-year secular trends, and prevalence of uterine fibroid diagnoses and describe the proportion of symptomatic women. STUDY DESIGN: We performed a retrospective population-based cohort study of women, aged 18e65 years, enrolled 2005 through 2014 in Kaiser Permanente Washington. Uterine fibroid diagnoses identified by International Classification of Diseases, Ninth Revision codes and potential covariates were extracted from computerized databases. Women with prior hysterectomy and, for incidence estimates, women with prior fibroid diagnoses were excluded. Linear trends in incidence rates over the 10-year study period were evaluated using Poisson regression models. Rates and trend tests were examined for all women, by age groups, and by race/ethnicity. RESULTS: Associated International Classification of Diseases, Ninth Revision symptom-related codes were observed in 90% of incident cases. Incidence rates for fibroid diagnoses were highest for the age group 45e49 years, 240.3 per 10,000 woman-years in 2014, and for black women across all years. Overall age-adjusted estimated incidence rates declined during the 10-year study interval, from 139.4 per 10,000 woman-years in 2005 to 101.4 in 2014 (P value trend .0008). Overall prevalence in 2014 was 9.6%, and was highest among women aged 50e54 years (15.9%). Black women had higher prevalence (18.5%) than other racial/ethnic groups. CONCLUSION: We found a decreasing trend of new uterine fibroid diagnoses among predominantly symptomatic women ages 18e65 years in a recent 10-year interval. This finding was due, perhaps in part, to secular trends of decreasing hysterectomies. Nonetheless, uterine fibroids remain a common health burden, with a prevalence of nearly 10%. Rates are disproportionately high and occur at younger ages for black women, and possibly for other non-white racial/ethnic groups. These findings are of concern, as current available long-term medical therapies remain limited.

Adenomyosis incidence, prevalence and treatment: United States population-based study 2006–2015

“…The KPWA population generally reflects the underlying community it serves with respect to age, race, and sex. 10 The cohort consisted of all women aged 16e60 years in 2006e2015 enrolled at KPWA for a minimum of 2 years with at least 1 health care utilization at KPWA in the 2 years before cohort entry on January 1, 2006, through December 31, 2015. We further restricted to women who did not have a record of hysterectomy at least 61 days (or 2 months) prior to cohort entry.…”

Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis

“…The prevalence is known to increase with age, especially among women aged 50–54 years (15.9%). 1 UFs usually result in a series of chronic symptoms, such as heavy menstrual bleeding, pelvic pain and bladder dysfunction. In addition, UFs may cause reproductive problems including infertility and pregnancy complications.…”

Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening

“…Smooth muscle tumors of the uterus are extremely common while the HLRCC syndrome is uncommon. A US population‐based study of uterine fibroids showed an overall prevalence of 9.6%, and a 15.9% prevalence among 50 to 54‐year‐old women 17 . The true prevalence of HLRCC is not known; it is estimated to affect roughly 1 in 200 000 individuals and has been reported in approximately 300 families worldwide, but it is likely underdiagnosed.…”